EBV and MS: A summary of the research to date

11th October 2023

A one-page summary of MSIF's recently published information statement on EBV and MS.

MSIF welcomes its newest member from the Republic of North Macedonia

5th October 2023

The National Association for MS in the Republic of North Macedonia join’s MSIF's global network of MS…

What if your experience of living with MS helped thousands of people?

26th September 2023

People with MS are invited to participate in a global survey to better understand what has the…

Shining a spotlight on mental health in MS: resources from the MSIF movement

15th September 2023

Discover mental health resources from MS organisations across the globe for World Mental Health Day.

How accessible are MS treatments in the MENA region?

30th August 2023

New publication highlights regional disparities in the management of MS

New prevalence and incidence data now available in the Atlas of MS

21st August 2023

Latest figures show prevalence of MS continues to increase in many countries

Why is it important for people affected by MS to be actively involved in research?

1st August 2023

New survey launched by the International Progressive MS Alliance

WHO’s decision brings hope to people with MS worldwide

25th July 2023

Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time

Is it MS or something else?

20th July 2023

Global MS experts update recommendations for the differential diagnosis of MS

Professor Xavier Montalban wins the prestigious MS Charcot Award

30th June 2023

Professor Montalban wins the 2023 lifetime achievement award for outstanding research into the understanding and treatment of…

Global webcast on ending MS progression

27th June 2023

Research advances that could lead to breakthrough treatments in progressive MS

Global barriers to MS diagnosis

16th June 2023

Importance of training and education for healthcare professionals is highlighted in new publication